Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoston for Endometrial Repair After Induced Abortion
NCT06546397Phase 1Recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- May 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estradiol + dydrogesterone in endometrial injury (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoints: The thickness of the endometrium at Day 21 and Cycle normalization rate. Started May 2024; status: recruiting.
02
Drugs
estradiol + dydrogesterone
03
Conditions
endometrial injury
Beyond the preview
Go deeper on NCT06546397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06546397.